Free Trial
NASDAQ:BBLG

Bone Biologics (BBLG) Stock Price, News & Analysis

$1.19
-0.05 (-4.03%)
(As of 09/6/2024 ET)
Today's Range
$1.13
$1.28
50-Day Range
$1.10
$2.72
52-Week Range
$1.00
$10.56
Volume
54,483 shs
Average Volume
841,944 shs
Market Capitalization
$1.31 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
BBLG stock logo

About Bone Biologics Stock (NASDAQ:BBLG)

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.

BBLG Stock Price History

BBLG Stock News Headlines

The solution to fast food’s wage hike crisis
Shake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post. With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.
BBLG Continues Progress as Testing Proceeds
The solution to fast food’s wage hike crisis
Shake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post. With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.
See More Headlines
Receive BBLG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bone Biologics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/09/2024
Today
9/07/2024
Next Earnings (Estimated)
11/12/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical appliances & supplies
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:BBLG
Previous Symbol
NASDAQ:BBLG
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

Net Income
$-8,950,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$1.61 per share

Miscellaneous

Free Float
957,000
Market Cap
$1.31 million
Optionable
Not Optionable
Beta
0.31
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Mr. Jeffrey Frelick (Age 58)
    CEO & President
    Comp: $325k
  • Ms. Deina H. Walsh (Age 60)
    Chief Financial Officer
    Comp: $212.5k
  • Dr. Shun'ichi Kuroda
    Co-Founder & Member of Scientific Advisory Board

BBLG Stock Analysis - Frequently Asked Questions

How have BBLG shares performed this year?

Bone Biologics' stock was trading at $4.52 at the beginning of 2024. Since then, BBLG stock has decreased by 73.7% and is now trading at $1.19.
View the best growth stocks for 2024 here
.

How were Bone Biologics' earnings last quarter?

Bone Biologics Co. (NASDAQ:BBLG) released its earnings results on Friday, August, 9th. The company reported ($0.67) EPS for the quarter, topping analysts' consensus estimates of ($1.39) by $0.72.

When did Bone Biologics' stock split?

Shares of Bone Biologics reverse split on the morning of Wednesday, December 20th 2023. The 1-8 reverse split was announced on Wednesday, December 20th 2023. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, December 20th 2023. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split.

When did Bone Biologics IPO?

Bone Biologics (BBLG) raised $8 million in an IPO on Wednesday, October 13th 2021. The company issued 1,510,455 shares at a price of $5.25 per share.

How do I buy shares of Bone Biologics?

Shares of BBLG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:BBLG) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners